Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reckitt is a global leader in consumer health, hygiene, and nutrition, operating a vast portfolio of well-known brands including Mucinex, Gaviscon, Nurofen, and Enfamil. The company focuses on providing innovative solutions for everyday health needs, ranging from over-the-counter (OTC) medications for respiratory and gastrointestinal relief to specialized infant and adult nutrition products. Reckitt's business is structured around three primary global business units: Health, Hygiene, and Nutrition, with a significant presence in North America through its RBNA division. The company is committed to sustainable growth and scientific excellence, maintaining a robust pipeline of product enhancements and new formulations to address evolving consumer wellness trends.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RBNA.